CCM
IMA

Coldstream Capital Management’s ImageneBio Inc IMA Stock Holding History

Coldstream Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44
Closed -$672 – 2167
2025
Q1 		$672 Buy
+44
New +$759 ﹤0.01% 3276

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Coldstream Capital Management's IMA Position: Q2 2025 in Review

Coldstream Capital Management sold out of ImageneBio Inc (IMA) in Q2 2025, closing a stake of 44 shares — an estimated $672 sold.

Coldstream Capital Management first reported a position in IMA in Q1 2025 and held it in 1 quarter. The position peaked at $672 in Q1 2025. 40 funds tracked by Wall St. Rank hold IMA as of Q2 2025.

  • Coldstream Capital Management reported no remaining ImageneBio Inc position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 44 ImageneBio Inc shares in Q2 2025, an estimated $672.
  • Coldstream Capital Management first reported a position in ImageneBio Inc in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's ImageneBio Inc position peaked at $672 in Q1 2025.
  • 40 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.